Serina Therapeutics receives NYSE notification [Seeking Alpha]
Serina Therapeutics, Inc. (SER)
Company Research
Source: Seeking Alpha
The company reported stockholders' equity of $1.6M as of Sept. 30, 2025, and has recorded losses in three of the past four fiscal years ended Dec. 31, 2024. The company must file a plan by Feb. 8, 2026, detailing how it will meet NYSE listing requirements by July 9, 2027, following a notice of non-compliance. Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters Sign Up More on Serina Therapeutics Seeking Alpha's Quant Rating on Serina Therapeutics Historical earnings data for Serina Therapeutics Financial information for Serina Therapeutics Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
SER
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SER alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SER alerts
High impacting Serina Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SER
News
- Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' EquityGlobeNewswire
- Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry [Yahoo! Finance]Yahoo! Finance
- Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of ChemistryGlobeNewswire
- Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 ProgramGlobeNewswire
- Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business HighlightsGlobeNewswire
SER
Sec Filings
- 1/15/26 - Form 8-K
- 1/14/26 - Form 4
- 1/9/26 - Form 4
- SER's page on the SEC website